Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study

BACKGROUND: The prognosis of heart failure (HF) after early stage breast cancer (EBC) treatment with anthracyclines or trastuzumab is not well-characterized. METHODS: Using administrative databases, women diagnosed with HF after receiving anthracyclines or trastuzumab for EBC in Ontario during 2007...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Qadir, Husam, Tai, Felicia, Croxford, Ruth, Austin, Peter C., Amir, Eitan, Calvillo-Argüelles, Oscar, Ross, Heather, Lee, Douglas S., Thavendiranathan, Paaladinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288484/
https://www.ncbi.nlm.nih.gov/pubmed/34187164
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.008110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288484/
https://www.ncbi.nlm.nih.gov/pubmed/34187164
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.008110

Ejemplares similares